Q: On Aug 4,CLR reports strong Q2 results & positive outlook for 2015.The 2nd half is normally much stronger.In june/2015 raised $46m @ $12.25 per share in addition to a non-brokered private placement of $15m @ $12.25(bought by insiders)As per 5I,directors owns 69%.CLR has been talking of acquistions & buying assets Your expert opinion & is it buyable now. Thanks so much for your usual opinions & services
Q: MNW's ceo Rick McBee appeared on BNN this morning stating that the sell-off on Aug 6 does NOT reflect its growth.Solid growth in Cloud(21%) & Mobile(35%).Executing well vs profitable growth strategy.Recent acquistion,Mavenir is integrating well & will grow revenue. A report fr.CIBC today stating $13 target price basing on 12 x 2016 EPS of $1.10 & a rating of Sector Outperformer.Further,the street modelling is off due to acquistion & normal Q3 seasonality.(EPS--7-13 cents(MNW) vs 18(street)vs 11(CIBC) ).Likes as 1)revenue growth fr.Cloud & Mobile.2)EBITDA is tracking on expectations.3)trading @ 8 x 2016 EPS.Free cash flow yield of 11%. Your expert view & is this a good entry point.Appreciate your usual great services & views.
Wondering if you can give me your analysis on Pengrowth. What does it's balance sheet look like? More importantly does it look like its high debt and high dividend yield are sustainable?
Q: Hi; At what point is The Score a table thumping buy? I have a full position but have just a little cash to add to something. Or is there something better from your growth portfolio? Thanks for the great service
Q: Hi Guys
Last week you answered my question regarding investing $40,000.00 outside my RRSP.Thank you.
Next and last question, is now the time to invest or should I wait and if waiting,where should the TSX be when I invest.
Thnaks
Michael
I see a lot of bio/medical service stocks are being taken to the woodshed today for reasons unknown. I plan on selling a bit of AYA and building my holding in GUD to a full position (5.1% of my total portfolio) and then not touching it for at least 3 years. What do you think?
From the growth portfolio, these stocks are down and i'm considering taking a position. Would you suggest getting now a full position or start with only half.
Are there any other from this portfolio that you would start a position now?
Q: What do you think of the recent developments at Knight Therapeutics Inc? Their New Drug Submission has been accepted for review by Health Canada and they have entered into an exclusive distribution agreement with Ember Therapeutics.GUD seems to have dropped 7% in the last couple days on the news. It seems to me the news was positive but is there something I'm missing? Thank-you for your service.
Q: Hello Team,
Could it be possible that the drop in CSU is not merely profit taking but rather a reaction to the recent news about a shareholder with over 1,000,000 shares? Could you explain and comment on this news released on august 5th?
Thank you. Gail
Q: CSU has fallen dramatically in the last week and I can only attest to 'one' proven fact -- the Frank Effect. My brother purchased this stock this week, and true to form, every time he purchases a stock, it plummets. If you feel it would be of use to your members, I would be pleased to share with everyone when Frank wishes to buy shares in a company -- in that way, we could all avoid some serious losses in our chosen companies. I am concerned enough about this stock market phenomenon, that I make a point of having a portfolio diverse enough from his. Share if you think it's important. : )